Company profile: in the early 1990s, our company began to study effectivedrugs for the treatment of hepatitis B. first of all, we bought a batch ofdrugs to treat hepatitis B in more than a dozen countries in Southeast Asia fortesting, analysis and research. And sum up the experience of treating hepatitisB in more than ten big hospitals of countries. After more than six years ofrepeated research, clinical practice, with the support of the Center for MedicalResearch at Columbia University, the Department of Hepatology, the experts inbiology, and the experts in plants, we finally used pollen polysaccharide rawmaterials to treat hepatitis B. When Pollen Polysaccharide enters the humanbody, a kind of active immune ribozyme (Ribozyme) is produced to mobilize humanNK immune cells and remove hepatitis virus hidden in liver and blood withoutany side effects, so as to achieve the purpose of treating hepatitis B. BecauseQinggan jiedu Dan has remarkable curative effect, it was awarded the effectivereport on hepatitis in 2001 in the famous American medical journal. To millionsof hepatitis B patients to bring the latest hope of recovery。